Table 1 Baseline characteristics
n (%) or median (95 % Bonett-Price confidence interval) | |
|---|---|
Number of subjects | 607 |
Men, n. (%) | 399 (66 %) |
sTNFR1 (ng/l) | 2567 (2488–2645) |
sTNFR2 (ng/l) | 6010 (5818–6202) |
Age (years) | 61 (60.5–61.5) |
Current smoking | 108 (18 %) |
Glomerular filtration (ml/min/1.73 m2) | 77 (75–78) |
GFR <60 ml/min/1.73 m2 | 58 (10 %) |
Albumin-creatinine ratio (g/mol) | 0.60 (0.50–0.70) |
Microalbuminuria | 94 (15 %) |
Diabetic kidney disease | 140 (23 %) |
Systolic blood pressure (mmHg) | 137 (135–138) |
Diastolic blood pressure (mmHg) | 80 (79–81) |
HbA1c (IFCC, mmol/mol) | 54 (53–56) |
LDL-cholesterol (mmol/l) | 2.7 (2.6–2.8) |
HDL-cholesterol (mmol/l) | 1.2 (1.15–1.25) |
High sensitivity C-reactive protein (mg/l) | 1.60 (1.35–1.85) |
Interleukin-6 (ng/l) | 2.15 (1.99–2.31) |
Statin treatment | 327 (53 %) |
Antihypertensive treatment | 390 (64 %) |